About this trial
This pragmatic multicenter randomized controlled trial (RCT) includes adult participants with an acute humeral shaft fracture to compare surgical fixation of humeral shaft fracture to non-surgical treatment with early identification and treatment of delayed union by a patient-reported outcome after 52 weeks. The trial population of 287 participants The trial population is divided in two age-groups due to the changes in DASH score by age. The definition of delayed union differs in the young and elderly population to consider dissimilarity in bone healing rates and the timepoint for crossover is therefor different between the groups. Participants will be randomized 1:1 between non-surgical treatment and surgical treatment. The primary outcome is the Disability of Arm, Shoulder and Hand (DASH) score at 52 weeks, and is assessor blinded. The secondary outcomes are DASH score earlier than 52 weeks, EQ-5D-5L, pain assessed by visual analogue score, Constant-Murley score including elbow range of motion and anchor-questions collected at all timepoints throughout the trial. All complications will be reported including; infection, nerve or vascular injury, surgical revisions (implant malpositioning, hardware failure, aseptic loosening and peri-implant fracture), major adverse cardiovascular events, other major adverse events and mortality. SHAFT will provide information on the effectiveness of two standard treatments for humeral shaft fractures, while taking the dilemmas within the population into account.
Eligibility criteria
Qualifiers
Fracture types 12A-C (OTA/AO classification)
Treatment within 14 days from trauma
Age 18-64 years for SHAFT-Y and ≥65 years for SHAFT-E
Patients must understand the information given and be able to read and speak Danish, Swedish or Norwegian to complete the study paperwork
Disqualifiers
Inability to give informed consent
Undisplaced shaft fracture (less than a cortex-wide displacement in all radiographic plane)
Vascular injury in ipsilateral arm
Polytrauma (defined as a trauma with one or more concurrent fractures to the upper extremities or other trauma absolute indications for surgical intervention)
Trial design
Treatments tested in this trial
- Surgical treatment
- Non-surgical treatment
Treatment groups
Sponsors and collaborators
Kolding Sygehus
Lead sponsor
Copenhagen University Hospital, Hvidovre
Collaborator
Zealand University Hospital
Collaborator
Oslo University Hospital
Collaborator
Helse Stavanger HF
Collaborator
Sahlgrenska University Hospital
Collaborator
Uppsala University Hospital
Collaborator
Odense University Hospital
Collaborator
Hospital of Southern Jutland
Collaborator
Slagelse Hospital
Collaborator
Aalborg University Hospital
Collaborator
University Hospital, Umeå
Collaborator
Nordsjaellands Hospital
Collaborator
Holbaek Sygehus
Collaborator
Aarhus University Hospital
Collaborator
Copenhagen University Hospital at Herlev
Collaborator
University Hospital Bispebjerg and Frederiksberg
Collaborator
Viborg Regional Hospital
Collaborator
Karolinska University Hospital
Collaborator
Danderyd Hospital
Collaborator
Tampere University Hospital
Collaborator
Helsinki University Central Hospital
Collaborator